Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Acute pyelonephritis].

F Bruyère1, G Cariou, J-P Boiteux

  • 1CHU Bretonneau, 2 boulevard Tonnellé, 37044 Tours cedex, France. f.bruyere@chu-tours.fr

Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|June 17, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short CIAFU recommendations on the screening and management of asymptomatic bacteriuria in immunocompromised patients.

The French journal of urology·2025
Same author

What's new in the diagnosis and treatment of human brucellosis?

Infectious diseases now·2025
Same author

FIRE Stones: impact of forced diuresis on the residual fragment rate after flexible ureteroscopy for destruction of kidney stones with laser-protocol for a randomized controlled two-parallel group multicenter trial with blinding evaluation.

Trials·2024
Same author

A proposed mathematical model to help preoperative planning between RIRS and MiniPerc for renal stones between 10 and 20 mm using holmium:Yag laser (Cyber Ho): the stone management according to size-hardness (SMASH) score.

Urolithiasis·2024
Same author

[Infections and male infertility].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

Clinical practice recommendations for infectious disease management of diabetic foot infection (DFI) - 2023 SPILF.

Infectious diseases now·2023
Same journal

["Connected device for monitoring patients treated by prostatectomy: Implementation and qualitative assessment"].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
Same journal

[Role of nurses specializing in oncology to support the care journey for patients with penile cancer].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
Same journal

[Pre- and post-prostatectomy rehabilitation by the certified nurse-urologist pair (REHAB): Feasibility study].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
Same journal

[Genitourinary complications after pelvic radiotherapy: Diagnosis and management].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
Same journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same journal

[Male contraception].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
See all related articles

Prompt initial management of pyelonephritis by identifying complicating factors. Treatment varies from ambulatory fluoroquinolones for uncomplicated cases to surgical renal drainage and extended IV antibiotics for severe or recurrent infections.

Area of Science:

  • Nephrology
  • Urology
  • Infectious Diseases

Background:

  • Pyelonephritis, a kidney infection, requires prompt management.
  • Identifying complicating factors is crucial for effective treatment strategies.

Purpose of the Study:

  • To outline the diagnostic and therapeutic approach for pyelonephritis.
  • To differentiate management based on disease severity and presence of complications.

Main Methods:

  • Initial assessment includes abdominal ultrasound and X-ray to rule out urinary dilation or stones.
  • CT scans are indicated for patients with complicating factors or recurrent infections.
  • Treatment strategies involve ambulatory or inpatient care with specific antibiotic regimens.

Main Results:

Related Experiment Videos

  • Uncomplicated pyelonephritis can be treated ambulatory with 2 weeks of fluoroquinolones or third-generation cephalosporins.
  • Complicated or severe cases necessitate hospitalization with initial treatment including third-generation cephalosporin plus aminoglycoside for 3-6 weeks.
  • Surgical renal drainage is indicated when complicating factors are present.

Conclusions:

  • Effective pyelonephritis management hinges on accurate diagnosis and risk stratification.
  • Tailored treatment, considering complications and severity, optimizes patient outcomes.
  • Prompt intervention, including appropriate antibiotic therapy and surgical drainage when needed, is key.